title: Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a "status quo" gene.
abstract: The ability of the well known morphogen, retinoic acid (RA), as well as 1,25-dihydroxy-vitamin D3 (VD), whose receptor complex binds a DNA consensus sequence related to that of the retinoic acid receptor, to regulate expression of the retinoblastoma (RB) tumor suppressor gene in a context of induced cell differentiation was characterized. HL-60 human promyelocytic leukemia cells were induced to undergo myeloid or monocytic terminal cell differentiation by these agents. To investigate the potential coupling between down-regulation of RB and c-myc oncogene expression with cell differentiation, dose response relationships for the induced down-regulation of RB and c-myc expression were compared with each other and with induced cell differentiation. The total amount of RB protein per cell increased as cells advanced through the cell cycle, but the amount of RB protein relative to the total cell mass remained approximately constant. Treated with RA or VD, an early progressive decrease in cellular content of the RB protein occurred in all cell cycle phases well before any cell cycle modulation or phenotypic differentiation. For a differentiation-defective variant HL-60 cell line, failure to differentiate was preceded by a failure to down-regulate cellular levels of the RB protein. In dose response experiments, progressively increasing RA or VD concentrations caused progressively greater reductions in RB as well as c-myc expression with an increasing fraction of cells terminally differentiating. For both RA and VD, the dose response relationships for reductions in RB and c-myc expression were similar suggesting that their down-regulation may be coupled. These observations are consistent with a model whereby RB expression acts as a cellular brake to sustain a developmentally ordained state of differentiation (i.e., preserve the "status quo"); and the down-regulation of heterogeneously distributed RB protein per cell below a threshold is part of the metabolic cascade culminating in terminal cell differentiation. Thus, RB may have a role in this developmental context.
authors.affiliation: Department of Pathology, Veterinary College, Cornell University, Ithaca, NY 14853-6401.
authors.forename: A
authors.initials: A
authors.lastname: Yen
authors.forename: S
authors.initials: S
authors.lastname: Chandler
authors.forename: M E
authors.initials: ME
authors.lastname: Forbes
authors.forename: Y K
authors.initials: YK
authors.lastname: Fung
authors.forename: A
authors.initials: A
authors.lastname: T'Ang
authors.forename: R
authors.initials: R
authors.lastname: Pearson
mesh_terms: D002117:Calcitriol / Q000502:physiology*; D002453:Cell Cycle / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics*; D004247:DNA / Q000378:metabolism; D015536:Down-Regulation / Q000502:physiology; D005786:Gene Expression Regulation / Q000502:physiology; D016161:Genes, Retinoblastoma / Q000502:physiology*; D016259:Genes, myc / Q000502:physiology*; D006801:Humans; D016160:Retinoblastoma Protein / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D016160:Retinoblastoma Protein; D014212:Tretinoin; D004247:DNA; D002117:Calcitriol